Ampio Pharmaceuticals. Inc.   Report issue

For profit Phase 3
Founded: Greenwood Village CO United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2013
NCT01821677
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ampio Pharmaceuticals. Inc. | Lead Investigator

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 1)

Edema (Phase 3)

Macular Edema (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 15
  • # of Trial APIs: 3